Kennedy Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.22M | Sell |
132,045
-18,379
| -12% | -$726K | 0.12% | 285 |
|
|
2025
Q1 | $4.54M | Sell |
150,424
-72,854
| -33% | -$2.2M | 0.11% | 302 |
|
|
2024
Q4 | $7.81M | Buy |
223,278
+61,202
| +38% | +$2.14M | 0.17% | 198 |
|
|
2024
Q3 | $6.49M | Sell |
162,076
-92,267
| -36% | -$3.7M | 0.14% | 249 |
|
|
2024
Q2 | $12.1M | Buy |
254,343
+4,816
| +2% | +$230K | 0.26% | 117 |
|
|
2024
Q1 | $10.8M | Buy |
249,527
+21,102
| +9% | +$915K | 0.22% | 154 |
|
|
2023
Q4 | $11.6M | Sell |
228,425
-10,210
| -4% | -$517K | 0.25% | 126 |
|
|
2023
Q3 | $10.8M | Buy |
238,635
+8,374
| +4% | +$380K | 0.26% | 111 |
|
|
2023
Q2 | $9.45M | Buy |
230,261
+47,836
| +26% | +$1.96M | 0.22% | 158 |
|
|
2023
Q1 | $6.52M | Buy |
182,425
+43,244
| +31% | +$1.55M | 0.19% | 197 |
|
|
2022
Q4 | $5.26M | Sell |
139,181
-5,614
| -4% | -$212K | 0.15% | 249 |
|
|
2022
Q3 | $6.4M | Buy |
144,795
+25,113
| +21% | +$1.11M | 0.19% | 187 |
|
|
2022
Q2 | $4.43M | Buy |
119,682
+109,834
| +1,115% | +$4.07M | 0.12% | 292 |
|
|
2022
Q1 | $365K | Buy |
9,848
+2,315
| +31% | +$85.8K | 0.01% | 569 |
|
|
2021
Q4 | $229K | Sell |
7,533
-531
| -7% | -$16.1K | ﹤0.01% | 600 |
|
|
2021
Q3 | $270K | Sell |
8,064
-265
| -3% | -$8.87K | 0.01% | 612 |
|
|
2021
Q2 | $332K | Buy |
8,329
+321
| +4% | +$12.8K | 0.01% | 604 |
|
|
2021
Q1 | $360K | Buy |
8,008
+1,797
| +29% | +$80.8K | 0.01% | 633 |
|
|
2020
Q4 | $351K | Buy |
+6,211
| New | +$351K | 0.01% | 612 |
|
|
2017
Q1 | – | Sell |
-27,154
| Closed | -$1.3M | – | 742 |
|
|
2016
Q4 | $1.3M | Sell |
27,154
-22,846
| -46% | -$1.09M | 0.02% | 648 |
|
|
2016
Q3 | $1.83M | Buy |
+50,000
| New | +$1.83M | 0.04% | 587 |
|